Lifetime lover of science, especially biomedical research. Spent years in academics, business development, research, and traveling the world shilling for Big Pharma. I love sports, mostly college basketball and football, hockey, and baseball. I enjoy great food and intelligent conversation. And a delicious morning coffee!
Major physician groups are issuing their own RSV, flu, and COVID vaccine recommendations due to confusion from the CDC and ACIP. Highlighted recommendations include vaccinating all children aged 6 months and older against the flu, and specific COVID and RSV… Read More »Physician groups update COVID, RSV, flu vaccine recommendations
The US FDA has approved four COVID vaccines targeting the XFG variant for the 2026-2027 season, developed by Moderna, Pfizer and BioNTech, Novavax, and Sanofi. While the vaccines are available for high-risk individuals, the CDC’s lack of guidance leads to… Read More »FDA approves four new COVID vaccines for the 2026-27 season
A recent study indicates that recipients of the recombinant shingles vaccine (Shingrix) experience a lower risk of cardiovascular events compared to those who received the live-attenuated vaccine (Zostavax). While causality is not established, Shingrix may also provide ancillary benefits, including… Read More »Recombinant shingles vaccine improves cardiovascular outcomes
A recent study underscores the rotavirus vaccine’s effectiveness in preventing death from rotavirus-related acute gastroenteritis in children. Prior to its 2006 introduction in the U.S., rotavirus caused widespread illness and fatalities. As health recommendations shift, the study urges timely vaccination… Read More »Vaccine prevents gastroenteritis deaths from rotavirus
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran, significantly reduces melanoma recurrence and spread in a phase 3 trial. Combining intismeran with Merck’s Keytruda showed notable improvements in patient outcomes, marking a pivotal… Read More »New mRNA vaccine cuts recurrence and spread of melanoma
According to CDC data, kindergarten vaccination rates for 2025-2026 have declined, with exemptions reaching an all-time high, primarily due to non-medical refusals. Key vaccines like MMR and polio saw slight decreases. This worrying trend poses risks for community immunity and… Read More »2025-2026 school vaccination rates drop, exemptions rise
A recent study on a peptide vaccine targeting KRAS mutations demonstrates promising results for pancreatic cancer treatment. It elicited T-cell responses in 90% of patients, showing safety and persistence of responses for up to two years. These findings support further… Read More »Pancreatic cancer peptide vaccine shows promise in patients
On August 10, 2026, President Trump issued an Executive Order promoting misinformation about vaccines, supported by HHS Secretary Robert F Kennedy Jr. Their claims misrepresent vaccine safety and dosages, contradict established scientific findings. This order could create confusion and jeopardize… Read More »False claims from Trump during vaccine Executive Order signing
An online tool developed by the Center for Unbiased Science and Health, in partnership with CIDRAP, visually illustrates the risks of vaccines versus the diseases they prevent. With rising measles outbreaks in the USA, this tool aims to clarify misconceptions… Read More »Online tool shows vaccine vs disease risks
Moderna’s mRNA-1010 flu vaccine has received FDA approval for adults aged 50 and older, marking it as the first mRNA-based flu vaccine in the U.S. It demonstrates 26.6% higher effectiveness than standard vaccines. While adverse events were more frequent, most… Read More »FDA approves first mRNA flu vaccine for people over 50